There has long been a need for biomarkers of disease activity in lupus nephritis (LN). Such
markers ideally would be capable of detecting early sub-clinical disease and could be used …

Screening for disease‐specific autoantibodies may be useful in asymptomatic ANA‐positive
individuals as a means of evaluating the risk of developing a systemic autoimmune disease …

The clinical progression of the severe acute respiratory syndrome coronavirus 2 infection,
coronavirus 2019 (COVID‐19), to critical illness is associated with an exaggerated immune …

Objective The premature atherosclerosis seen in patients with systemic lupus erythematosus
(SLE) is not explained by traditional risk factors. SLE disease activity, such as renal …

Background Cytokine storm is a marker of coronavirus disease 2019 (COVID-19) illness
severity and increased mortality. Immunomodulatory treatments have been repurposed to …

Background Most individuals with autoimmune and other immune disorders undergo initial
evaluation in the community setting. Since misdiagnosis of systemic autoimmune diseases …

Introduction The high-affinity receptor for IgG Fcγ/CD64 is critical for the development of
lupus nephritis (LN). Cross-linking Fc receptor on recruited monocytes by IgG-containing …

Objective. Anti-cyclic citrullinated peptide (CCP) antibodies are a serological marker for
rheumatoid arthritis (RA); up to 10%–15% of patients with systemic lupus erythematosus (SLE) …

Autoantibodies have been used extensively as a useful biomarker in systemic lupus
erythematosus and other autoimmune rheumatic diseases. Antinuclear antibodies by …

Objective To generate a core set of items to develop classification criteria for scleroderma
renal crisis ( SRC ) using consensus methodology. Methods An international, multidisciplinary …